2016
DOI: 10.1021/jacs.5b12557
|View full text |Cite
|
Sign up to set email alerts
|

Total Synthesis and Biological Evaluation of Natural and Designed Tubulysins

Abstract: A streamlined total synthesis of N(14)-desacetoxytubulysin H (Tb1) based on a C-H activation strategy and a short total synthesis of pretubulysin D (PTb-D43) are described. Applications of the developed synthetic strategies and technologies to the synthesis of a series of tubulysin analogues (Tb2-Tb41 and PTb-D42) are also reported. Biological evaluation of the synthesized compounds against an array of cancer cells revealed a number of novel analogues (e.g., Tb14), some with exceptional potencies against certa… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
110
0
4

Year Published

2016
2016
2024
2024

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 83 publications
(115 citation statements)
references
References 69 publications
0
110
0
4
Order By: Relevance
“…C−H activation was utilized to achieve an efficient synthesis of N 14 ‐desacetoxytubulysin H (Tb1) and pretubulysin D, alongside the derivatives tubulysin BCP 330 a and cubane 330 b . The synthesized compounds were biologically evaluated with an array of cancer cell lines.…”
Section: Application Of Rigid‐linear Linkers In Small Molecule Drugsmentioning
confidence: 99%
See 1 more Smart Citation
“…C−H activation was utilized to achieve an efficient synthesis of N 14 ‐desacetoxytubulysin H (Tb1) and pretubulysin D, alongside the derivatives tubulysin BCP 330 a and cubane 330 b . The synthesized compounds were biologically evaluated with an array of cancer cell lines.…”
Section: Application Of Rigid‐linear Linkers In Small Molecule Drugsmentioning
confidence: 99%
“…CÀHa ctivation was utilized to achieve an efficient synthesis of N 14 -desacetoxytubulysin H( Tb1) and pretubulysinD,a longside the derivativest ubulysin BCP 330 a and cubane 330 b. [422] The synthesized compounds were biologically evaluated with an array of cancerc ell lines. Notable results included the novel BCP analogue Tb14 330 a,w hich showedh igh potencies against certain cell lines such as uterine sarcoma andh uman Review embryonick idney cell line.…”
Section: Non-natural Peptidesmentioning
confidence: 99%
“…[96] 4.5. N 14 -Desacetoxytubulysin H Based on the retrosynthetic disconnections shown in Scheme 9A and employing aC ÀHactivation tactic,our total synthesis of N 14 -desacetoxytubulysin H( 224) [98] is summarized in Scheme 9B.T hus,f ragments 225 and 226 were combined in the presence of PhI(OCOCF 3 ) 2 and TMSN 3 to provide ketone 227,w hose asymmetric reduction furnished selectively hydroxy compound 228.S tandard manipulations of this intermediate led to carboxylic acid 229,w hose sequential coupling with fragments 230 and 231 proceeded smoothly to generate tripeptide 232,asshown in Scheme 9B. Fragment 233 was then introduced into the growing molecule to afford N 14 -desacetoxytubulysin Hmethyl ester (234), from which N 14 -desacetoxytubulysin H(224)was liberated through ester hydrolysis and replacement of the lost acetyl group,a s summarized in Scheme 9B.Applying the developed synthetic strategies and technologies in this program we designed, synthesized, and biologically evaluated in collaboration with our biology partners dozens of tubulysin analogues as potential ADC payloads,t wo of which (235 and 236)a re shown in Scheme 9C together with their high potencies against certain cancer or cancer-like cells.…”
Section: Tubulysin Dmentioning
confidence: 99%
“…Because of their high potencies, these compounds are suitable as payloads for ADCs and other selective delivery systems. In an effort to optimize their biopharmaceutical properties, we developed a streamlined total synthesis of N 14 ‐desacetoxytubulysin H ( 49 , Figure ) and pretubulysin D with the intention of applying it to the synthesis of a variety of analogues for biological screening. Figure outlines our successful total synthesis of N 14 ‐desacetoxytubulysin H ( 49 , 13 steps, longest linear sequence from aldehyde H ).…”
Section: Applications Of Total Synthesis To Potential Cancer Therapiesmentioning
confidence: 99%
“…The synthesis was then completed through intermediates 71 – 73 as shown in Figure . From the many analogues we synthesized and tested, Tb‐20 , Tb‐32 and Tb‐33 were among the most notable, exhibiting extremely low picomolar cytotoxicities (see Figure ). Further studies with Tb‐32 and other tubulysin analogues are continuing.…”
Section: Applications Of Total Synthesis To Potential Cancer Therapiesmentioning
confidence: 99%